scholarly article | Q13442814 |
editorial | Q871232 |
P50 | author | Mary-Ann Davies | Q79181149 |
P2093 | author name string | Jorge Pinto | |
P2860 | cites work | Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches | Q26774246 |
Optimizing drugs to reach treatment targets for children and adolescents living with HIV | Q26774255 | ||
Sequencing paediatric antiretroviral therapy in the context of a public health approach | Q26774261 | ||
Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children | Q26774267 | ||
Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach | Q26859055 | ||
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa | Q28535251 | ||
Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis | Q28731813 | ||
Pediatric HIV — A Neglected Disease? | Q29013261 | ||
The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants. | Q30382184 | ||
Integration of HIV in child survival platforms: a novel programmatic pathway towards the 90-90-90 targets. | Q30386700 | ||
Social protection: potential for improving HIV outcomes among adolescents | Q30386703 | ||
Epidemiology of HIV and AIDS among adolescents: current status, inequities, and data gaps | Q30830419 | ||
Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre- post comparison | Q33519698 | ||
Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey | Q33528970 | ||
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis | Q33619587 | ||
Barriers to provider-initiated testing and counselling for children in a high HIV prevalence setting: a mixed methods study | Q33670289 | ||
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa | Q33797490 | ||
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment | Q34083742 | ||
Early antiretroviral therapy improves neurodevelopmental outcomes in infants | Q34093261 | ||
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants | Q34175450 | ||
Absence of detectable HIV-1 viremia after treatment cessation in an infant | Q34379777 | ||
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? | Q34379806 | ||
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment | Q34430211 | ||
Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries | Q34513045 | ||
Estimating future trends in paediatric HIV. | Q34585140 | ||
Early viral suppression improves neurocognitive outcomes in HIV-infected children | Q35095168 | ||
Pubertal development in HIV-infected African children on first-line antiretroviral therapy. | Q35126455 | ||
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa | Q35156697 | ||
Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting | Q35160696 | ||
Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis. | Q35246507 | ||
Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents | Q35338750 | ||
The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. | Q36043393 | ||
Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe | Q36081713 | ||
Variability of growth in children starting antiretroviral treatment in southern Africa | Q36277597 | ||
Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis | Q36349677 | ||
The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children | Q36349683 | ||
90-90-90--Charting a steady course to end the paediatric HIV epidemic | Q36349696 | ||
Achieving 90-90-90 in paediatric HIV: adolescence as the touchstone for transition success | Q36349706 | ||
Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. | Q36390881 | ||
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial | Q36521955 | ||
Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration | Q36565583 | ||
Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment | Q36754505 | ||
Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus | Q36807963 | ||
Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa | Q37171622 | ||
Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa | Q37226114 | ||
HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis | Q37341984 | ||
Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa | Q37344340 | ||
Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania | Q37390909 | ||
Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review | Q37698748 | ||
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review | Q37923050 | ||
Health for the world's adolescents: a second chance in the second decade | Q38296514 | ||
Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda | Q38876653 | ||
Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit | Q42244906 | ||
How should access to antiretroviral treatment be measured? | Q42609061 | ||
Building our youth for the future | Q43167440 | ||
The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis | Q44434681 | ||
Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa | Q48660616 | ||
P433 | issue | Suppl 6 | |
P921 | main subject | teenager | Q1492760 |
P304 | page(s) | 20745 | |
P577 | publication date | 2015-12-02 | |
P1433 | published in | Journal of the International AIDS Society | Q6296158 |
P1476 | title | Targeting 90-90-90--don't leave children and adolescents behind | |
P478 | volume | 18 |
Q90633843 | 90-90-90 cascade analysis on reported CLHIV infected by mother-to-child transmission in Guangxi, China: a modeling study |
Q58570297 | Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya |
Q38944299 | Association between self-reported adherence and HIV viral load suppression among older children and adolescents |
Q30376419 | Challenges and opportunities of optimal breastfeeding in the context of HIV option B+ guidelines |
Q57174670 | Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya |
Q92559670 | Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets |
Q89594112 | Cognition, structural brain changes and systemic inflammation in adolescents living with HIV on antiretroviral therapy |
Q91694834 | Comparison of the prevalence rates of HIV infection between men who have sex with men (MSM) and men in the general population in sub-Saharan Africa: a systematic review and meta-analysis |
Q89943488 | Correlates of ART Use Among Newly Diagnosed HIV Positive Adolescent Girls and Young Women Enrolled in HPTN 068 |
Q60641763 | Initiation of antiretroviral therapy after the critical neuronal developmental period of the second postnatal year affects white matter microstructure in adolescents living with HIV |
Q90301807 | Mortality in a Cohort of HIV-Infected Children: A 12-Month Outcome of Antiretroviral Therapy in Makurdi, Nigeria |
Q47097059 | Neglected Population, Neglected Right: Children Living with HIV and the Right to Science |
Q69682534 | Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia |
Q54974619 | Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. |
Q61808891 | Qualitative situational analysis of palliative care for adolescents with cancer and HIV in South Africa: healthcare worker perceptions |
Q36046415 | Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review. |
Q51410002 | The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa. |
Q59802863 | Traversing the cascade: urgent research priorities for implementing the 'treat all' strategy for children and adolescents living with HIV in sub-Saharan Africa |
Search more.